Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:November 29, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorsLast Updated:November 29, 2019Completed
Condition(s):Pulmonary FibrosisLast Updated:April 28, 2020Completed
Condition(s):Sepsis; Septic ShockLast Updated:September 29, 2017Completed
Condition(s):Kidney TransplantationLast Updated:January 12, 2024Completed
Condition(s):Respiratory TuberculosisLast Updated:November 9, 2023Recruiting
Condition(s):Chronic Granulomatous DiseaseLast Updated:January 22, 2021Completed
Condition(s):COVID-19 Respiratory Infection; Viral PneumoniaLast Updated:May 27, 2022Completed
Condition(s):IFN-Gamma Therapy; CGD Gene Mutation; CGD Response to IFNg; CGD – Chronic Granulomatous Disease; Immunodeficiency DiseaseLast Updated:September 20, 2017Terminated
Condition(s):UveitisLast Updated:July 2, 2017Completed
Condition(s):Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Lung DiseaseLast Updated:November 6, 2007Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.